EUVIMEDEUVIMED entdecken
Crossref

Prevalence, incidence and residual risk of HBV, HCV and HIV in Turkish Red Crescent blood donors: A 9‐year survey initiated with the implementation of nucleic acid testing (2015–2023)

Mehmet Bakır Saygan, Soner Yilmaz, Can Murat Beker, Özgür Rüştü Güner, Fatma Meriç Yilmaz

Vox Sanguinis · 2026-11 · 121 (11) · 1653-1664

DOI: 10.1111/vox.70324 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vox Sanguinis, online erschienen am 29.07.2026. Verfasst von Mehmet Bakır Saygan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Middle Anatolia Regional Blood Centre, Turkish Red Crescent, Ankara, Türkiye. Hauptthemen laut MEDLINE: Hepatitis B, Hepatitis C, Blood Donors, HIV Infections. Die Arbeit nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives Nucleic acid testing (NAT) has improved blood safety by shortening the diagnostic window period (WP) for transfusion‐transmissible infections. Within the context of a national NAT‐based screening programme, this study evaluated temporal trends for hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) among Turkish Red Crescent blood donors between 2015 and 2023. Materials and Methods A retrospective analysis was conducted on 22,494,116 blood donations screened by serology and NAT. Prevalence, incidence and residual risk (RR) were estimated using standard incidence/WP models. Temporal trends were evaluated using linear regression, and NAT yield was assessed cumulatively.

Results

The overall confirmed positivity (per 100,000 donors) was 288.5 for HBV, 16.2 for HCV and 14.8 for HIV. HBV and HCV showed significant downward trends ( p < 0.01), while HIV rose significantly ( p < 0.01). Cumulative NAT yields were 189.35, 2.94 and 2.15 per million donations for HBV, HCV and HIV, respectively. Between 2015 and 2023, the estimated overall RR per million donations declined for HBV (634.79 to 238.34) and HCV (1.69 to 0.99), but rose for HIV (4.08 to 11.40). Notably, the rising HIV RR—contrasting with the decline for HCV—was driven by increasing repeat‐donor incidence and differences in the WP models used for risk estimation.

Conclusion

While NAT‐based screening was associated with low, declining RR for HBV and HCV, the rising HIV trajectory is concerning. This underscores the need for enhanced behavioural screening and donor selection strategies alongside molecular testing to address rising HIV risks.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis BHepatitis CBlood DonorsHIV InfectionsHepatitis B virusHepacivirusHumansTurkeyIncidencePrevalenceRetrospective StudiesFemaleMaleBlood DonationAdultHIVNucleic Acid Amplification Techniques

Stichwörter der Autor:innen

blood donorsblood safetynucleic acid testingresidual riskserological screeningtransfusion‐transmissible infections

Autor:innen und Institutionen

  • Middle Anatolia Regional Blood Centre, Turkish Red Crescent, Ankara, Türkiye.
  • Department of Medical Microbiology, University of Health Sciences, Gülhane Training and Research Hospital, Ankara, Türkiye.
  • Aegean Regional Blood Centre, Turkish Red Crescent, Izmir, Türkiye.
  • Managing Board, Turkish Red Crescent, Ankara, Türkiye.

Zitieren

APA

Saygan, M. B., Yilmaz, S., Beker, C. M., Güner, Ö. R., & Yilmaz, F. M. (2026). Prevalence, incidence and residual risk of HBV, HCV and HIV in Turkish Red Crescent blood donors: A 9‐year survey initiated with the implementation of nucleic acid testing (2015–2023). Vox Sanguinis, 121(11), 1653-1664. https://doi.org/10.1111/vox.70324

Vancouver

Saygan MB, Yilmaz S, Beker CM, Güner ÖR, Yilmaz FM. Prevalence, incidence and residual risk of HBV, HCV and HIV in Turkish Red Crescent blood donors: A 9‐year survey initiated with the implementation of nucleic acid testing (2015–2023). Vox Sanguinis. 2026;121(11):1653-1664. doi:10.1111/vox.70324

BibTeX
@article{Saygan2026,
  author = {Saygan, Mehmet Bakır and Yilmaz, Soner and Beker, Can Murat and Güner, Özgür Rüştü and Yilmaz, Fatma Meriç},
  title = {Prevalence, incidence and residual risk of HBV, HCV and HIV in Turkish Red Crescent blood donors: A 9‐year survey initiated with the implementation of nucleic acid testing (2015–2023)},
  journal = {Vox Sanguinis},
  year = {2026},
  volume = {121},
  number = {11},
  pages = {1653--1664},
  doi = {10.1111/vox.70324}
}
Kostenlos starten →